A molecular intelligence platform translating circRNA into biological insight.
By translating circRNA into molecular intelligence, CircPath™ supports research applications spanning biological discovery through translational research.
Investigate the biological processes underlying neurological disease.
Identify and evaluate novel circRNA biomarkers associated with disease biology.
Characterize biological differences across patient populations and research cohorts.
Support translational research, target identification, and clinical trial strategies.
Investigate biological patterns associated with disease progression and future risk.
CircPath™ is Circular Genomics' proprietary molecular intelligence platform that discovers, validates, and translates brain-derived circular RNA into biological insight.
Built on the unique biology of circRNA, CircPath™ provides a foundation for the next generation of precision neurology research.
Discover 1600+ combines whole-transcriptome circRNA sequencing with pathway-level analysis, enabling researchers to investigate biological patterns across individual samples, patient populations, and longitudinal studies.
By profiling more than 1,600 brain-derived circRNAs, Discover 1600+ provides a broader view of disease biology, patient heterogeneity, and the molecular pathways underlying neurological disease.
AD Predict is a CircPath™ research application designed to support research into future cognitive impairment and Alzheimer's disease symptom onset among cognitively unimpaired individuals.
By identifying biological patterns associated with future disease progression, AD Predict enables researchers to investigate Alzheimer's disease years before symptoms appear.
While Alzheimer's disease is the initial focus of CircPath™, the biology of circRNA has the potential to support future research applications across a broad range of neurological and neuropsychiatric conditions.